+499.5%
MRNA vs NI
+1.4%
+498.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NI | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.6% | -1.6% | -2.5% |
| 7D | +5.5% | +2.0% | +3.5% | +6.5% |
| 30D | +158.7% | -3.5% | +162.3% | +159.2% |
| 3M | +182.1% | -9.1% | +191.3% | +187.6% |
| 6M | +151.8% | -11.8% | +163.7% | +161.0% |
| YTD | +393.6% | +1.1% | +392.5% | +360.5% |
| 1Y | +499.5% | +6.7% | +492.8% | +464.8% |
| All | +499.5% | +1.4% | +498.1% | +464.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NI.
Daily Out/Under-Performance
Portfolio return minus NI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling